title: [Vaccination of newborns with high risk of tuberculosis in a French maternity hospital].
abstract: BACKGROUND
  The early vaccination with BCG of children with a high risk of tuberculosis straight from the maternity hospital has been recommended since October 2005. However, this recommendation has not often been followed. Practitioners feared that the suspension of the mandatory character of the BCG vaccine dating from July 2007 would result in a decrease in vaccine coverage. The goal of this study was to assess a program for early vaccination with BCG in the maternity hospital for high-risk children.
  
  
  METHODS
  Intradermal vaccination with BCG-SSI of high-risk newborns, as defined by the Conseil Supérieur d'Hygiène Publique de France, at the maternity hospital of Versailles from May 2007 to May 2008.
  
  
  RESULTS
  Six hundred and sixty children (35% of births with a sex ratio of 1.13) fulfilled criteria for vaccination in the maternity hospital. Among the high-risk newborns, 596 (89%), were vaccinated. The geographic origin of one or both parents was the main indication (98.6%) for the vaccination. Three main practitioners (two pediatricians and one nurse) performed 72.6% of the BCG intradermal injections. The other BCG vaccinations were given by occasional practitioners: pediatricians, a midwife, or medical students. A papule was subsequently observed more often when the practitioner was experienced: 96.8% for the main practitioners, 83.5% for the occasional practitioners. Fifty-six (8.3%) parents refused vaccination for their eligible newborn.
  
  
  CONCLUSIONS
  From our experience, the early vaccination of the at-risk of tuberculosis newborn is well accepted in the maternity hospital and presents very few technical problems for an experienced team.
authors.affiliation: Service de pédiatrie, centre hospitalier de Versailles, Le Chesnay, France. madommergues@orange.fr
authors.forename: M-A
authors.initials: MA
authors.lastname: Dommergues
authors.forename: F
authors.initials: F
authors.lastname: Robichon
authors.forename: S
authors.initials: S
authors.lastname: Soltane
authors.forename: S
authors.initials: S
authors.lastname: Refol
authors.forename: P
authors.initials: P
authors.lastname: Panel
authors.forename: P
authors.initials: P
authors.lastname: Foucaud
mesh_terms: D001500:BCG Vaccine / Q000008:administration & dosage*; D005260:Female; D005602:France; D019983:Guideline Adherence; D006291:Health Policy; D006771:Hospitals, Maternity; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration; D007231:Infant, Newborn; D007271:Injections, Intradermal; D008297:Male; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies; D012306:Risk; D018570:Risk Assessment; D012307:Risk Factors; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*; D014611:Vaccination / Q000379:methods / Q000706:statistics & numerical data*
chemical_list: D001500:BCG Vaccine